Blackstone Group $400 million investment in YiChang HEC ChangJiang Pharmaceutical

17/8/2018

Financial investment

Value:

$ 400 million

Status:

Announced

Date:

17/8/2018

Overview:

YiChang HEC ChangJiang Pharmaceutical has issued $400 million convertible notes.
The issuer has privately placed the notes to four funds controlled by Blackstone Group.

Daniel Semerdzhiev - Data analyst

Jurisdiction:

China

Deal type:

Financial investment

Practice area:

Banking

Governing law:

China

Industry sector:

Pharmaceuticals and life sciences

Firm:

Freshfields Bruckhaus Deringer

Party: YiChang HEC ChangJiang Pharmaceutical (Borrower)

Lawyers: Bing Guan, Richard Wang, Yuxin Shen

Related deals